Assessment of nebivolol efficacy in experimental models of toxoplasmosis: insights into parasite burden reduction and neuronal protection-Reference-Cited by-同舟云学术

Assessment of nebivolol efficacy in experimental models of toxoplasmosis: insights into parasite burden reduction and neuronal protection

Published:2024-08 Issue:8 Volume:123 Page:
ISSN:0932-0113
Container-title:Parasitology Research
language:en
Short-container-title:Parasitol Res

Author:

da Silva Bellini Ramos Amanda Bruno,Torres Tayline,dos Reis Luis Felipe Cunha,Lambert Gabriel Carvalho,Colombo Fábio Antônio,Marques Marcos José,Reimão Juliana Quero^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00436-024-08318-7.pdf

Reference27 articles.

1. Abdulkareem NM, Bhat R, Powell RT, Chikermane S, Yande S, Trinh L, Abdelnasser HY, Tabassum M, Ruiz A, Sobieski M, Nguyen ND, Park JH, Johnson CA, Kaipparettu BA, Bond RA, Johnson M, Stephan C, Trivedi MV (2022) Screening of GPCR drugs for repurposing in breast cancer. Front Pharmacol 13:1049640. https://doi.org/10.3389/fphar.2022.1049640

2. Alanazi AD, Alnomasy SF (2023) Immunomodulatory, antioxidant, and anti-inflammatory activities of green synthesized copper nanoparticles for treatment of chronic Toxoplasma gondii infection. Pharmaceuticals 7:1574. https://doi.org/10.3390/ph16111574

3. Ben-Harari RR, Goodwin E, Casoy J (2017) Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: a systematic review. Drugs R D 17(4):523–544. https://doi.org/10.1007/s40268-017-0206-8

4. Cockcroft J (2007) A review of the safety and efficacy of nebivolol in the mildly hypertensive patient. Vasc Health Risk Manag 3(6):909–917

5. Daher D, Shaghlil A, Sobh E, Hamie M, Hassan ME, Moumneh MB, Itani S, El Hajj R, Tawk L, El Sabban M, El Hajj H (2021) Comprehensive overview of toxoplasma gondii-induced and associated diseases. Pathogens 10(11):1351